Editorial: On medication abortion, the Supreme Court may actually do the right thing
It always seemed farfetched that anti-abortion doctors could argue that they have the right to ask a court to severely restrict a drug approved by the U.S. Food and Drug Administration simply because they don’t want to treat women who might experience complications.
Do they even have standing to bring this case? Do they have any proof they have been so harmed or injured that it justifies restricting FDA-approved access to mifepristone, the first in a two-drug
